Medicinal cannabis is a legal treatment in Australia as a prescription medicine.
TGA advises that cannabis is not a first line treatment; it can only be used after standard treatments have been unsuccessful or have caused unacceptable adverse effects, except in the case of patients in palliative care.
Clinical studies are being conducted on the use of medicinal cannabis to treat a variety of medical conditions. They include but are not limited to the following indications:
In general, products may cost approximately $5 to $10 per day on average in Australia, depending on the amount prescribed and pharmacy dispensing fee.
Reference: FreshLeaf Analytics Q3 2019 Australian Medicinal Cannabis Market Report - Patient, Product and Pricing Analysis
Regrettably, subsidies are not available for unregistered medicinal cannabis products through the Pharmaceutical Benefits Scheme at this time. Certain private health insurance funds cover non-PBS pharmaceuticals. Please contact your private health fund to check if unregistered medicinal cannabis products are covered.
Xativa® is an unregistered prescription medication available through the Special Access (SAS-B) or Authorised Prescriber (AP) Schemes in Australia. Access to these products requires TGA (Therapeutic Goods Administration) approval for individual patients (SAS-B) or classes of patients (AP).
Here’s step by step guide on how to access medicinal cannabis in Australia:
The first step is for patients to see their usual treating doctor, GP or specialist. Your doctor must be an Australian-registered medical practitioner and should have a good understanding of your medical condition(s) and access to your medical records.
Our Xativa® Hub directory provides a list of doctors who are familiar with our product. Their location and contact details are provided with their consent so that you may contact them for the purposes of patient access enquiries for medicinal cannabis. This directory is only accessible to registered and verified user accounts.
It is the responsibility of the doctor to research and compare products to decide if cannabinoid therapy is suitable for their patients. TGA applications under SAS-B or AP for unregistered medicinal cannabis require documentation confirming the product meets the safety and quality requirements set out in Therapeutic Goods Order No 93 (TGO93). Xativa® meets these requirements.
Any specific product information, including pricing is available only to registered healthcare professionals in Australia. Your doctor or pharmacist can send product enquiries through:
With the patient’s consent, practitioners can apply for federal and state approval (requirements differ between states) for a medicinal cannabis prescription.
The application must include the following information:
Who can apply?
This varies depending on the state/territory. Currently in all states except Tasmania, a GP can initiate an application.
A letter of support from a specialist is required for the following:
Upon receipt of approval from both TGA and State Health Department (for Tasmania only for Schedule 4 medicinal cannabis products), the script together with the approval(s) will need to be sent, by either the doctor or patient, to a pharmacy. The pharmacy can place orders for products to wholesalers or distributors with reference to the approved script.
A pharmacist can only dispense product to a patient upon receipt of an original prescription and a copy of the relevant TGA and State Health approval(s).
We also have a Directory Page with doctor and pharmacist contact information (this page is accessible only to registered and verified user accounts). You may contact these clinics and pharmacies for product access enquiries.
If travelling domestically within Australia
You can travel with medicinal cannabis but ensure you do the following:
If travelling internationally outside Australia
You can travel with medicinal cannabis but ensure you do the following:
The Office of Drug Control recommends that all Australians who are planning to travel overseas with medication follow the same advice given for travellers entering Australia under the traveller’s exemption. Visit https://www.odc.gov.au/travellers for more information
It is absolutely critical to check each country’s legislation before you travel. If you are carrying medicinal cannabis on a plane but you are unaware of the legislation of your destination country, it is recommended you leave your product on the plane. Most countries have very strict rules regarding certain types of medications being brought into their country. Cannabis is still illegal in most countries.
As a registered medical doctor in Australia you are eligible to prescribe unregistered medicinal cannabis to your patients so long as you do not fall into the following category:
In addition, a letter of support from a specialist is required for the following:
Unregistered medicinal cannabis supply is available through the Special Access (SAS-B) or Authorised Prescriber (AP) Schemes in Australia. Access to these products requires TGA (Therapeutic Goods Administration) approval for individual patients (SAS-B) or classes of patients (AP).
Once your application is submitted, TGA approval generally takes up to 48 hours.
When granted approval, you will be able to access a PDF attachment containing 1) TGA SAS-B approval and 2) State approval (where applicable)
Once the approval(s) are received, you can write a prescription:
A scanned copy of the corresponding TGA approval letter (SAS-B or AP) must be provided when placing an order.
Firstly, please ensure you have received an original copy of the doctor prescription, and a scanned copy of the TGA approval letter (SAS-B approval or Authorised Prescriber).
Visit our order form page to place an order (this order form is accessible only to registered & verified doctor and pharmacist accounts).
We may contact you by the phone number or email address details you have provided in your Pharmacist profile on the Xativa hub as required regarding your order.
You understand and acknowledge that all users of this website (“Website”) are responsible for their own medical care, treatment, and oversight. The information, including but not limited to, text, graphics, images, pricing and other materials contained on the Website are for informational purposes only. No information on the Website is intended to be a substitute for professional medical advice, diagnosis or treatment. You understand and acknowledge that you should always seek the advice of your physician or other qualified health care provider with any questions or concerns you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the Website.
Although we take efforts to keep the information on our Website updated, we cannot guarantee that the information on our Website reflects the most up-to-date research. The information on this Website or on the linked websites should not be considered current, complete, error-free or exhaustive, nor should you rely on such information to recommend a course of treatment for you or any other individual. Reliance on any information provided on this Website or any linked websites is solely at your own risk.